Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.
Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.
复制标题
DOI:
10.1161/circresaha.117.310705
复制
发表时间:
2017-07-07
影响因子:
20.1
通讯作者:
Straub AC
中科院分区:
文献类型:
--
作者:
Rahaman MM;Nguyen AT;Miller MP;Hahn SA;Sparacino-Watkins C;Jobbagy S;Carew NT;Cantu-Medellin N;Wood KC;Baty CJ;Schopfer FJ;Kelley EE;Gladwin MT;Martin E;Straub AC
Soluble guanylate cyclase (sGC) heme iron, in its oxidized state (Fe3+), is desensitized to nitric oxide (NO) and limits cyclic guanosine 3′, 5′-monophosphate (cGMP) production needed for downstream activation of PKG-dependent signaling and blood vessel dilation. While reactive oxygen species are known to oxidize the sGC heme iron, the basic mechanism(s) governing sGC heme iron recycling to its NO-sensitive, reduced state, remain poorly understood. Oxidant challenge studies show vascular smooth muscle cells have an intrinsic ability to reduce oxidized sGC heme iron and form protein-protein complexes between cytochrome b5 reductase 3 (Cyb5R3), also known as methemoglobin reductase, and oxidized sGC. Genetic knockdown and pharmacological inhibition in VSMCs reveal Cyb5R3 expression and activity is critical for NO-stimulated cGMP production and vasodilation. Mechanistically, we show Cyb5R3 directly reduces oxidized sGC required for NO sensitization as assessed by biochemical, cellular, and ex vivo assays. Together, these findings identify new insights into NO-sGC-cGMP signaling and reveal Cyb5R3 as the first identified physiological sGC heme iron reductase in VSMCs, serving as a critical regulator of cGMP production and PKG dependent signaling.